140 related articles for article (PubMed ID: 36708011)
1. Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant.
Skaug B; Guo X; Li YJ; Charles J; Pham KT; Couturier J; Lewis DE; Bracaglia C; Caiello I; Mayes MD; Assassi S
Rheumatology (Oxford); 2023 Sep; 62(9):3197-3204. PubMed ID: 36708011
[TBL] [Abstract][Full Text] [Related]
2. Comment on: Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant.
Zervou MI; Goulielmos GN
Rheumatology (Oxford); 2023 Nov; 62(11):e325-e326. PubMed ID: 36971567
[No Abstract] [Full Text] [Related]
3. Association of the DNASE1L3 rs35677470 polymorphism with systemic lupus erythematosus, rheumatoid arthritis and systemic sclerosis: Structural biological insights.
Zervou MI; Andreou A; Matalliotakis M; Spandidos DA; Goulielmos GN; Eliopoulos EE
Mol Med Rep; 2020 Dec; 22(6):4492-4498. PubMed ID: 33173951
[TBL] [Abstract][Full Text] [Related]
4. Global genetic analysis of all single nucleotide polymorphisms in exons of the human deoxyribonuclease I-like 3 gene and their effect on its catalytic activity.
Ueki M; Fujihara J; Takeshita H; Kimura-Kataoka K; Iida R; Yuasa I; Kato H; Yasuda T
Electrophoresis; 2011 Jun; 32(12):1465-72. PubMed ID: 21692081
[TBL] [Abstract][Full Text] [Related]
5.
Serpas L; Chan RWY; Jiang P; Ni M; Sun K; Rashidfarrokhi A; Soni C; Sisirak V; Lee WS; Cheng SH; Peng W; Chan KCA; Chiu RWK; Reizis B; Lo YMD
Proc Natl Acad Sci U S A; 2019 Jan; 116(2):641-649. PubMed ID: 30593563
[TBL] [Abstract][Full Text] [Related]
6. Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.
Chan RWY; Serpas L; Ni M; Volpi S; Hiraki LT; Tam LS; Rashidfarrokhi A; Wong PCH; Tam LHP; Wang Y; Jiang P; Cheng ASH; Peng W; Han DSC; Tse PPP; Lau PK; Lee WS; Magnasco A; Buti E; Sisirak V; AlMutairi N; Chan KCA; Chiu RWK; Reizis B; Lo YMD
Am J Hum Genet; 2020 Nov; 107(5):882-894. PubMed ID: 33022220
[TBL] [Abstract][Full Text] [Related]
7. The deficiency of DNASE1L3 does not affect systemic sclerosis pathogenesis in two inducible murine models of the disease.
Garreau A; Santa P; Dubois M; Brisou D; Levionnois É; Laurent P; Ferriere A; Roubertie A; Loizon S; Duluc D; Blanco P; Contin-Bordes C; Truchetet ME; Sisirak V
Eur J Immunol; 2024 Jun; 54(6):e2350903. PubMed ID: 38576111
[TBL] [Abstract][Full Text] [Related]
8. Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity.
Sisirak V; Sally B; D'Agati V; Martinez-Ortiz W; Özçakar ZB; David J; Rashidfarrokhi A; Yeste A; Panea C; Chida AS; Bogunovic M; Ivanov II; Quintana FJ; Sanz I; Elkon KB; Tekin M; Yalçınkaya F; Cardozo TJ; Clancy RM; Buyon JP; Reizis B
Cell; 2016 Jun; 166(1):88-101. PubMed ID: 27293190
[TBL] [Abstract][Full Text] [Related]
9. Effects of nucleases on cell-free extrachromosomal circular DNA.
Sin ST; Deng J; Ji L; Yukawa M; Chan RW; Volpi S; Vaglio A; Fenaroli P; Bocca P; Cheng SH; Wong DK; Lui KO; Jiang P; Chan KCA; Chiu RW; Lo YMD
JCI Insight; 2022 Apr; 7(8):. PubMed ID: 35451374
[TBL] [Abstract][Full Text] [Related]
10. Arg206Cys substitution in
Coke LN; Wen H; Comeau M; Ghanem MH; Shih A; Metz CN; Li W; Langefeld CD; Gregersen PK; Simpfendorfer KR
Ann Rheum Dis; 2021 Jun; 80(6):782-787. PubMed ID: 33455918
[TBL] [Abstract][Full Text] [Related]
11. DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling.
Tusseau M; Lovšin E; Samaille C; Pescarmona R; Mathieu AL; Maggio MC; Selmanović V; Debeljak M; Dachy A; Novljan G; Janin A; Januel L; Gibier JB; Chopin E; Rouvet I; Goncalves D; Fabien N; Rice GI; Lesca G; Labalme A; Romagnani P; Walzer T; Viel S; Perret M; Crow YJ; Avčin T; Cimaz R; Belot A
J Clin Immunol; 2022 Aug; 42(6):1310-1320. PubMed ID: 35670985
[TBL] [Abstract][Full Text] [Related]
12. Caucasian-specific allele in non-synonymous single nucleotide polymorphisms of the gene encoding deoxyribonuclease I-like 3, potentially relevant to autoimmunity, produces an inactive enzyme.
Ueki M; Takeshita H; Fujihara J; Iida R; Yuasa I; Kato H; Panduro A; Nakajima T; Kominato Y; Yasuda T
Clin Chim Acta; 2009 Sep; 407(1-2):20-4. PubMed ID: 19559017
[TBL] [Abstract][Full Text] [Related]
13. Homeostatic Milieu Induces Production of Deoxyribonuclease 1-like 3 from Myeloid Cells.
Inokuchi S; Mitoma H; Kawano S; Nakano S; Ayano M; Kimoto Y; Akahoshi M; Arinobu Y; Tsukamoto H; Akashi K; Horiuchi T; Niiro H
J Immunol; 2020 Apr; 204(8):2088-2097. PubMed ID: 32188756
[TBL] [Abstract][Full Text] [Related]
14. An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3.
Zochling J; Newell F; Charlesworth JC; Leo P; Stankovich J; Cortes A; Zhou Y; Stevens W; Sahhar J; Roddy J; Nash P; Tymms K; Rischmueller M; Lester S; Proudman S; Brown MA
Arthritis Res Ther; 2014 Oct; 16(5):438. PubMed ID: 25332064
[TBL] [Abstract][Full Text] [Related]
15. Comparative characterization of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3).
Napirei M; Wulf S; Eulitz D; Mannherz HG; Kloeckl T
Biochem J; 2005 Jul; 389(Pt 2):355-64. PubMed ID: 15796714
[TBL] [Abstract][Full Text] [Related]
16. Systemic Lupus Erythematosus Patients with DNASE1L3·Deficiency Have a Distinctive and Specific Genic Circular DNA Profile in Plasma.
Gerovska D; Araúzo-Bravo MJ
Cells; 2023 Mar; 12(7):. PubMed ID: 37048133
[TBL] [Abstract][Full Text] [Related]
17. Unfolding the pathogenesis of scleroderma through genomics and epigenomics.
Tsou PS; Sawalha AH
J Autoimmun; 2017 Sep; 83():73-94. PubMed ID: 28526340
[TBL] [Abstract][Full Text] [Related]
18. Serum level of DNase1l3 in patients with dermatomyositis/polymyositis, systemic lupus erythematosus and rheumatoid arthritis, and its association with disease activity.
Zhao Q; Yang C; Wang J; Li Y; Yang P
Clin Exp Med; 2017 Nov; 17(4):459-465. PubMed ID: 28039554
[TBL] [Abstract][Full Text] [Related]
19. Targeting NETs using dual-active DNase1 variants.
Englert H; Göbel J; Khong D; Omidi M; Wolska N; Konrath S; Frye M; Mailer RK; Beerens M; Gerwers JC; Preston RJS; Odeberg J; Butler LM; Maas C; Stavrou EX; Fuchs TA; Renné T
Front Immunol; 2023; 14():1181761. PubMed ID: 37287977
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Impaired DNASE1L3 Activity to Anti-DNA Autoantibody Production in Systemic Lupus Erythematosus.
Mathapathi S; Chu CQ
Rheumatol Immunol Res; 2022 Mar; 3(1):17-22. PubMed ID: 36467024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
